BioLine RX Ltd (BLRX) — Free Cash Flow Generation Index

Latest as of December 2023: 1.00x

BioLine RX Ltd (BLRX) has a Free Cash Flow Generation Index of 1.00x as of December 2023. Free cash flow of ILA4.97 Million represents 1% of operating cash flow (ILA4.99 Million). See BioLine RX Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

1.00x

Free Cash Flow / Operating CF

Free Cash Flow

ILA4.97 Million

ILA

Operating Cash Flow

ILA4.99 Million

ILA

Capital Expenditures

ILA18.00K

ILA

BioLine RX Ltd Free Cash Flow Generation Index (2010–2010)

Historical FCF Generation Index trend for BioLine RX Ltd across 1 annual periods. Explore BioLine RX Ltd (BLRX) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for BioLine RX Ltd (2010–2010)

Year-by-year Free Cash Flow Generation Index for BioLine RX Ltd. For the full company profile including market capitalisation, see market value of BioLine RX Ltd.

Year	FCG Index	Free Cash Flow (ILA)	Operating CF	Capital Expenditures	YoY Change
2010	0.94x	ILA10.80 Million	ILA11.46 Million	ILA660.94K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).